Syndax Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AVTE
|
Aerovate Therapeutics, Inc. | $2.04 | $597.48 M | -6.84 | 51 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $16.32 | $1.29 B | -7.16 | 85 | $0 |
 COGT
|
Cogent Biosciences, Inc. | $11.09 | $802.20 M | -3.37 | 164 | $0 |
 CYTK
|
Cytokinetics, Incorporated | $56.66 | $6.05 B | -9.78 | 423 | $7.53 M |
 DICE
|
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 |
 DYN
|
Dyne Therapeutics, Inc. | $32.56 | $3.03 B | -7.77 | 152 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $28.40 | $1.65 B | -11.47 | 97 | $0 |
 INZY
|
Inozyme Pharma, Inc. | $5.17 | $286.39 M | -3.43 | 59 | $0 |
 KALV
|
KalVista Pharmaceuticals, Inc. | $11.35 | $492.76 M | -3.74 | 150 | $0 |
 KROS
|
Keros Therapeutics, Inc. | $61.06 | $1.76 B | -9.45 | 149 | $151,000 |
 KRTX
|
Karuna Therapeutics, Inc. | $329.83 | $12.60 B | -28.09 | 339 | $654,000 |
 LRMR
|
Larimar Therapeutics, Inc. | $6.62 | $611.84 M | -9.99 | 42 | $0 |
 MLYS
|
Mineralys Therapeutics, Inc. | $13.82 | $652.38 M | -6.03 | 28 | $0 |
 MRSN
|
Mersana Therapeutics, Inc. | $2.12 | $261.85 M | -1.91 | 123 | $36.86 M |
 MRUS
|
Merus N.V. | $51.80 | $3.50 B | -19.38 | 172 | $43.95 M |
 PCVX
|
Vaxcyte, Inc. | $111.39 | $7.72 B | -16.54 | 254 | $0 |
 PLRX
|
Pliant Therapeutics, Inc. | $11.53 | $672.63 M | -3.9 | 166 | $1.58 M |
 REPL
|
Replimune Group, Inc. | $11.48 | $485.18 M | -2.44 | 331 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $47.31 | $6.66 B | -10.51 | 443 | $11.58 M |
 STRO
|
Sutro Biopharma, Inc. | $3.66 | $303.46 M | -1.97 | 304 | $153.73 M |
 VRDN
|
Viridian Therapeutics, Inc. | $23.87 | $776.72 M | -2.71 | 94 | $314,000 |